RxDoctor Payments Data

Jennifer Hamilton-Cagle, APRN

Family · Murray, KYNPI 1700877552

Payments from drug & device makers

$698in general payments, 2019–2025

Across 39 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$155
  • Lilly USA, LLC$78
  • Novo Nordisk$73
  • Amgen$51
  • Astellas Pharma US Inc$47
  • Biohaven Pharmaceuticals, Inc.$43
  • plus $251 from 11 others

What the payments were for

  • Food & beverage$698100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$698 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$46,890
Medicare patients
177
Services billed
1,442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide19$20,135
FarxigaDapagliflozin Propanediol12$13,130
SynthroidLevothyroxine Sodium37$3,793
Levothyroxine Sodium131$1,420
Metoprolol Succinate93$1,393
Losartan Potassium119$1,290
Pantoprazole Sodium100$1,203
Potassium Chloride50$1,177
Irbesartan51$1,099
Rosuvastatin Calcium77$992
Famotidine53$850
Esomeprazole Magnesium25$739
Duloxetine Hcl33$702
Escitalopram Oxalate55$650
Omeprazole55$621

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$73$20,13519 claims
AstraZenecaFarxiga$35$13,13012 claims
AbbVieSynthroid$155$3,79337 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in Murray

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →